๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Application of Genomics in Preclinical Drug Safety Evaluation

โœ Scribed by Peter G. Lord; Alex Nie; Michael McMillian

Book ID
111316236
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
241 KB
Volume
98
Category
Article
ISSN
1742-7835

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A Comprehensive Guide to Toxicology in P
A Comprehensive Guide to Toxicology in Preclinical Drug Development || Impact of Product Attributes on Preclinical Safety Evaluation
โœ Brown, Jennifer G. ๐Ÿ“‚ Article ๐Ÿ“… 2013 ๐Ÿ› Elsevier ๐ŸŒ English โš– 126 KB

*A Comprehensive Guide to Toxicology in Preclinical Drug Development* is a resource for toxicologists in industry and regulatory settings, as well as directors working in contract resource organizations, who need a thorough understanding of the drug development process. Incorporating real-life case

Preclinical Safety Evaluation of Biophar
Preclinical Safety Evaluation of Biopharmaceuticals || Use of Animal Models of Disease in the Preclinical Safety Evaluation of Biopharmaceuticals
โœ Cavagnaro, Joy A. ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley & Sons, Inc. ๐ŸŒ English โš– 210 KB

the Goal Is To Provide A Comprehensive Reference Book For The Preclinicaldiscovery And Development Scientist Whose Responsibilities Span Target Identification, Lead Candidate Selection, Pharmacokinetics, Pharmacology, And Toxicology, And For Regulatory Scientists Whose Responsibilities Include The E

Application of genetics and genomics in
Application of genetics and genomics in drug development
โœ Mihael H. Polymeropoulos ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 54 KB ๐Ÿ‘ 2 views

Pharmacogenetics is capitalizing on the tools of the Human Genome Project to introduce the new genomic information into drug development. The applications vary from identifying individuals at risk for a disease, to developing gene signatures of drug efficacy and adverse effects. Pharmacogenetics is